Invention Grant
- Patent Title: Compositions and methods for treating CNS disorders
-
Application No.: US17545290Application Date: 2021-12-08
-
Publication No.: US11667668B2Publication Date: 2023-06-06
- Inventor: Francesco G. Salituro , Albert Jean Robichaud
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Kathryn D. Doyle; Jonathan P. O'Brien
- Main IPC: A61P25/24
- IPC: A61P25/24 ; C07J43/00
Abstract:
Provided herein is a compound of Formula (I)
or a pharmaceutically acceptable salt thereof, wherein R3a, R5, R6a, R6b, R17, R21a, R21b, Rm, Rn, R16a, R16b, R7a, R7b, R12a, R12b, R11a, R11b, R2a, R2b, R19, R4a, and R4b are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of CNS-related disorders.
or a pharmaceutically acceptable salt thereof, wherein R3a, R5, R6a, R6b, R17, R21a, R21b, Rm, Rn, R16a, R16b, R7a, R7b, R12a, R12b, R11a, R11b, R2a, R2b, R19, R4a, and R4b are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of CNS-related disorders.
Public/Granted literature
- US20220098231A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS Public/Granted day:2022-03-31
Information query
